ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SNG Synairgen Plc

4.755
0.105 (2.26%)
23 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.105 2.26% 4.755 4.52 4.99 - 189,060 16:35:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.36M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.65p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.36 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 8576 to 8597 of 99175 messages
Chat Pages: Latest  355  354  353  352  351  350  349  348  347  346  345  344  Older
DateSubjectAuthorDiscuss
01/6/2020
10:34
17p!!!News cycle could have an impact. However we'll get results here which will most likely determine which way this goes. Poor first read out and it will be done for the time being regardless of the good sets of data that follow.Looking at the report posted today the nebulised version is meant to be more effective than the injection. If the hospital trial shows data anywhere close to those numbers in terms of discharge and reduced mortality then you will see this go up. I don't disagree there are numerous challenges to get to market but the move in price won't factor that immediately. Have you seen the price on some of these testing companies? lol.
sainvestor
01/6/2020
10:25
I think it's a mistake to assume Lansdowne will be selling down to zero. That's not their normal MO. They will have taken profits and reduced exposure but that's very different from being out.

With a market cap of around £50m, these could re-rate very quickly on any further good news about INFA as a treatment option.

When Gilead released the initial results from Remdisavir, ignoring the Chinese data that suggested it didn't work, their market cap increased by close to $1bn.

From my reading, INFA treatment looks at least as good, if not better given the much lower adverse events profile.

waterloo01
01/6/2020
10:22
i dont think R has much to do with business dealings here,
spartan attack
01/6/2020
10:21
Marie is back! You are talking a lot of sense.

I agree that the R number is bound to go up and from a scientific point of view the easing of the lock down has been a shambles. They have changed so many things at once when the inevitable happens, we won't know which of the changes caused it. As a scientist I am just sitting here with my head in my hands.

nobbygnome
01/6/2020
10:20
LANDSOWNE hold 17,468,735 shares with the last file date being 6th May when they sold 1,596,604 shares. Link are the largest holder with 21,341,293 shares. This data is from my bloomberg.
markinvestor
01/6/2020
10:20
Yes in most instances, short term 17/20 unrealistic in norm circ. But The forced seller does change it a bit i think
spartan attack
01/6/2020
10:19
tburns,

the last update was 11/05/20 when they had sold down from 12.76% to 11.69%. Thought that they had to notify as certain levels were crossed? Or is it that they can can put in an order to sell remaining 11.69% and only need to notify when order is satisfied?

hairballradical
01/6/2020
10:18
SA,

17P or even 30P very unrealistic in short term.

Can't see even 35P before read out.

Remember, 2nd wave news and this will spike.

And we all know 2nd wave is inevitable...

idontflykathyy
01/6/2020
10:16
So a balancing act for Lansdowne to sell whatever they got left before the price reaches 35.
ramridge
01/6/2020
10:16
The months of April and May, saw a net distribution in total volume for the two months, of approx 6,2 million weighted, in a total volume circa 12.5 million or something like that

IF its correct that they need to offload, liquidity is doing them no favours. They will not get to offload all by 35p

So it depends on where they commenced. And the bottom line price for a profit average.

In my estimation, selling down to 26.5p will be ok for them i guess. But they probably have a 3rd party shorting it as they distribute to cover lack of liquidity

All in all, i dont see 31p being supported.

This will also force out retail buyers and smaller hold institutions/funds

SO your looking at sub 20p with ease imo, circa 17p, to start assessing it again

spartan attack
01/6/2020
10:11
I can't believe that sub 40p looks like it is coming into view. How many shares did they last have declared on their TR1, hopefully nearly out soon
tburns
01/6/2020
10:09
ram, there should be TR1 then.

Lansdowne overall are in deep red thanks to other exposure so guess they want to cover by selling here. They still up from their 35P purchase.

As i write - dropping more....

idontflykathyy
01/6/2020
10:07
According to SNG's website Lansdowne has approx 17m shares.
I did a rough calculation of 'sell' trades during the month of May, and it comes to around 30m shares.
Now comes the guesswork. If you reckon that half of the total is Lansdowne selling, then they must be nearly out.
My sense is that, at best they have all but sold down. At worst, another 2 or 3 weeks say.
This is only a guestimate guys.

ramridge
01/6/2020
09:59
Seller/s happy to make less and less profit.
wetdream
01/6/2020
09:58
Well hope you do. We can both make from both sides really.
spartan attack
01/6/2020
09:55
SA - I dont know whether COPD wil work or ongoing work related to COVID will be successful or not

But thing I know in next few days I'll get price of 50P+ easily and hence good share to ride now

idontflykathyy
01/6/2020
09:50
Bought more today at 43P

SA - what the hell you are doing here ?

Come back to Metro board... leave this guys here.

SNG spent a decade on COPD trial and now read out in few days so expect a massive spike sometime in mid june and you will look stupid lol

idontflykathyy
01/6/2020
09:50
Very positive.
sainvestor
01/6/2020
09:47
Interesting article in medRxiv on Thursday reporting on a trial using injected Interferon beta (IFN).

medRxiv is a medical archive that publishes preprints of medical research before peer review.

SNG's nebulized treatment should have higher efficacy than injected treatments.

Conclusion was this:

The 28-day overall mortality was significantly lower in the IFN then the control group (19% vs. 43.6% respectively)

.....significantly increased discharge rate on day 14 and decreased 28-day mortality

Bottom line - IFN works for significantly improved outcomes.

Report is here hxxps://www.medrxiv.org/content/10.1101/2020.05.28.20116467v1

asteria1
01/6/2020
09:20
https://www.trialsitenews.com/university-of-southampton-spinoff-venture-synairgen-expand-study-of-sng001-to-include-virtual-design-in-support-of-covid-19-patients/"The study team expects to be able to report preliminary top line data in July of this year."
sainvestor
01/6/2020
09:00
What the theory on no update on positions?
sainvestor
01/6/2020
08:46
Afraid we ain’t going anywhere much while the insti/s is/are off loading
imho

judijudi
Chat Pages: Latest  355  354  353  352  351  350  349  348  347  346  345  344  Older

Your Recent History

Delayed Upgrade Clock